FDA Clears geko Muscle Pump Activator to Prevent VTE

Home / Clinical Practice / FDA Clears geko Muscle Pump Activator to Prevent VTE

FDA Clears geko Muscle Pump Activator to Prevent VTE

OCTOBER 15TH, 2019   MEDGADGET EDITORS CARDIAC SURGERY, CARDIOLOGY, CRITICAL CARE, MEDICINE, REHAB

Venous thromboembolism (VTE) too often strikes bedridden patients in the hospital, and this is one of the main reasons that patients are put back on their feet as soon as possible. Inflatable wraps placed around the legs, which can raise the pressure, are a common way to prevent the condition. Now, a device called geko from Sky Medical Technology, a U.K. firm, has just been cleared by the FDA to stimulate the calf muscles, in turn increasing blood circulation, and helping to prevent VTE.

The device was previously only cleared to be used immediately after surgeries, but the geko muscle pump activator is now available for clinicians to use on all patients at risk of VTE.

It relies on the company’s OnPulse technology that stimulates the common peroneal nerve, creating properly timed contractions of the muscles that increase blood flow.

Here’s a video explaining how the geko works to prevent VTE:

Link: OnPulse technology info page…

Via: Sky Medical Technology

Leave a Reply

Your email address will not be published.